A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles
Conventionally, patients with irritable bowel syndrome (IBS) are subgrouped based on their predominant bowel habit. Given the relevance of psychological comorbidity to IBS symptoms, our aim was to explore an alternative approach to subgrouping by incorporating factors beyond stool form and frequency...
Saved in:
Published in | The American journal of gastroenterology Vol. 116; no. 2; pp. 372 - 381 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wolters Kluwer
01.02.2021
Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Conventionally, patients with irritable bowel syndrome (IBS) are subgrouped based on their predominant bowel habit. Given the relevance of psychological comorbidity to IBS symptoms, our aim was to explore an alternative approach to subgrouping by incorporating factors beyond stool form and frequency.
We collected demographic, symptom, and psychological health data from 1,375 adult subjects in the community who self-identified as having IBS, identifying 2 cohorts meeting either Rome III or Rome IV criteria. In each cohort, we performed latent class analysis, a method of model-based clustering, to identify specific subgroups (clusters). For each cluster, we drew a radar plot and compared these by visual inspection, describing cluster characteristics.
In total, 1,080 individuals met the Rome III criteria for IBS, and 811 met the Rome IV criteria. In both cohorts, a 7-cluster model was the optimum solution, and the characteristics of the clusters were almost identical between Rome III and IV. Four clusters were defined by the pattern of gastrointestinal symptoms (loose stools and urgency or hard stools and bloating), further differentiated by the presence of abdominal pain not relieved by defecation, and by the extent of psychological comorbidity. Two clusters had below-average gastrointestinal symptoms, differentiated by the extent of psychological comorbidity. The final cluster had well-above-average gastrointestinal symptoms and high levels of psychological comorbidity. The proportion of subjects with severe IBS symptom scores, high levels of perceived stress, and high levels of gastrointestinal symptom-specific anxiety was significantly higher in clusters with high psychological comorbidity (P < 0.001).
Latent class analysis identified 7 distinct IBS subgroups characterized by varying degrees of gastrointestinal symptoms, extraintestinal symptoms, and psychological comorbidity. Further research is needed to assess whether they might be used to direct treatment. |
---|---|
AbstractList | INTRODUCTION:Conventionally, patients with irritable bowel syndrome (IBS) are subgrouped based on their predominant bowel habit. Given the relevance of psychological comorbidity to IBS symptoms, our aim was to explore an alternative approach to subgrouping by incorporating factors beyond stool form and frequency.METHODS:We collected demographic, symptom, and psychological health data from 1,375 adult subjects in the community who self-identified as having IBS, identifying 2 cohorts meeting either Rome III or Rome IV criteria. In each cohort, we performed latent class analysis, a method of model-based clustering, to identify specific subgroups (clusters). For each cluster, we drew a radar plot and compared these by visual inspection, describing cluster characteristics.RESULTS:In total, 1,080 individuals met the Rome III criteria for IBS, and 811 met the Rome IV criteria. In both cohorts, a 7-cluster model was the optimum solution, and the characteristics of the clusters were almost identical between Rome III and IV. Four clusters were defined by the pattern of gastrointestinal symptoms (loose stools and urgency or hard stools and bloating), further differentiated by the presence of abdominal pain not relieved by defecation, and by the extent of psychological comorbidity. Two clusters had below-average gastrointestinal symptoms, differentiated by the extent of psychological comorbidity. The final cluster had well-above-average gastrointestinal symptoms and high levels of psychological comorbidity. The proportion of subjects with severe IBS symptom scores, high levels of perceived stress, and high levels of gastrointestinal symptom–specific anxiety was significantly higher in clusters with high psychological comorbidity (P < 0.001).DISCUSSION:Latent class analysis identified 7 distinct IBS subgroups characterized by varying degrees of gastrointestinal symptoms, extraintestinal symptoms, and psychological comorbidity. Further research is needed to assess whether they might be used to direct treatment. Conventionally, patients with irritable bowel syndrome (IBS) are subgrouped based on their predominant bowel habit. Given the relevance of psychological comorbidity to IBS symptoms, our aim was to explore an alternative approach to subgrouping by incorporating factors beyond stool form and frequency. We collected demographic, symptom, and psychological health data from 1,375 adult subjects in the community who self-identified as having IBS, identifying 2 cohorts meeting either Rome III or Rome IV criteria. In each cohort, we performed latent class analysis, a method of model-based clustering, to identify specific subgroups (clusters). For each cluster, we drew a radar plot and compared these by visual inspection, describing cluster characteristics. In total, 1,080 individuals met the Rome III criteria for IBS, and 811 met the Rome IV criteria. In both cohorts, a 7-cluster model was the optimum solution, and the characteristics of the clusters were almost identical between Rome III and IV. Four clusters were defined by the pattern of gastrointestinal symptoms (loose stools and urgency or hard stools and bloating), further differentiated by the presence of abdominal pain not relieved by defecation, and by the extent of psychological comorbidity. Two clusters had below-average gastrointestinal symptoms, differentiated by the extent of psychological comorbidity. The final cluster had well-above-average gastrointestinal symptoms and high levels of psychological comorbidity. The proportion of subjects with severe IBS symptom scores, high levels of perceived stress, and high levels of gastrointestinal symptom-specific anxiety was significantly higher in clusters with high psychological comorbidity (P < 0.001). Latent class analysis identified 7 distinct IBS subgroups characterized by varying degrees of gastrointestinal symptoms, extraintestinal symptoms, and psychological comorbidity. Further research is needed to assess whether they might be used to direct treatment. Conventionally, patients with irritable bowel syndrome (IBS) are subgrouped based on their predominant bowel habit. Given the relevance of psychological comorbidity to IBS symptoms, our aim was to explore an alternative approach to subgrouping by incorporating factors beyond stool form and frequency.INTRODUCTIONConventionally, patients with irritable bowel syndrome (IBS) are subgrouped based on their predominant bowel habit. Given the relevance of psychological comorbidity to IBS symptoms, our aim was to explore an alternative approach to subgrouping by incorporating factors beyond stool form and frequency.We collected demographic, symptom, and psychological health data from 1,375 adult subjects in the community who self-identified as having IBS, identifying 2 cohorts meeting either Rome III or Rome IV criteria. In each cohort, we performed latent class analysis, a method of model-based clustering, to identify specific subgroups (clusters). For each cluster, we drew a radar plot and compared these by visual inspection, describing cluster characteristics.METHODSWe collected demographic, symptom, and psychological health data from 1,375 adult subjects in the community who self-identified as having IBS, identifying 2 cohorts meeting either Rome III or Rome IV criteria. In each cohort, we performed latent class analysis, a method of model-based clustering, to identify specific subgroups (clusters). For each cluster, we drew a radar plot and compared these by visual inspection, describing cluster characteristics.In total, 1,080 individuals met the Rome III criteria for IBS, and 811 met the Rome IV criteria. In both cohorts, a 7-cluster model was the optimum solution, and the characteristics of the clusters were almost identical between Rome III and IV. Four clusters were defined by the pattern of gastrointestinal symptoms (loose stools and urgency or hard stools and bloating), further differentiated by the presence of abdominal pain not relieved by defecation, and by the extent of psychological comorbidity. Two clusters had below-average gastrointestinal symptoms, differentiated by the extent of psychological comorbidity. The final cluster had well-above-average gastrointestinal symptoms and high levels of psychological comorbidity. The proportion of subjects with severe IBS symptom scores, high levels of perceived stress, and high levels of gastrointestinal symptom-specific anxiety was significantly higher in clusters with high psychological comorbidity (P < 0.001).RESULTSIn total, 1,080 individuals met the Rome III criteria for IBS, and 811 met the Rome IV criteria. In both cohorts, a 7-cluster model was the optimum solution, and the characteristics of the clusters were almost identical between Rome III and IV. Four clusters were defined by the pattern of gastrointestinal symptoms (loose stools and urgency or hard stools and bloating), further differentiated by the presence of abdominal pain not relieved by defecation, and by the extent of psychological comorbidity. Two clusters had below-average gastrointestinal symptoms, differentiated by the extent of psychological comorbidity. The final cluster had well-above-average gastrointestinal symptoms and high levels of psychological comorbidity. The proportion of subjects with severe IBS symptom scores, high levels of perceived stress, and high levels of gastrointestinal symptom-specific anxiety was significantly higher in clusters with high psychological comorbidity (P < 0.001).Latent class analysis identified 7 distinct IBS subgroups characterized by varying degrees of gastrointestinal symptoms, extraintestinal symptoms, and psychological comorbidity. Further research is needed to assess whether they might be used to direct treatment.DISCUSSIONLatent class analysis identified 7 distinct IBS subgroups characterized by varying degrees of gastrointestinal symptoms, extraintestinal symptoms, and psychological comorbidity. Further research is needed to assess whether they might be used to direct treatment. |
Author | West, Robert Guthrie, Elspeth A. Ford, Alexander C. Black, Christopher J. Houghton, Lesley A. Yiannakou, Yan |
AuthorAffiliation | Leeds Institute of Health Sciences, University of Leeds, Leeds, UK Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK County Durham and Darlington NHS Foundation Trust, Durham, UK |
AuthorAffiliation_xml | – name: Leeds Institute of Health Sciences, University of Leeds, Leeds, UK – name: County Durham and Darlington NHS Foundation Trust, Durham, UK – name: Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK |
Author_xml | – sequence: 1 givenname: Christopher J. surname: Black fullname: Black, Christopher J. organization: Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK – sequence: 2 givenname: Yan surname: Yiannakou fullname: Yiannakou, Yan organization: County Durham and Darlington NHS Foundation Trust, Durham, UK – sequence: 3 givenname: Elspeth A. surname: Guthrie fullname: Guthrie, Elspeth A. organization: Leeds Institute of Health Sciences, University of Leeds, Leeds, UK – sequence: 4 givenname: Robert surname: West fullname: West, Robert organization: Leeds Institute of Health Sciences, University of Leeds, Leeds, UK – sequence: 5 givenname: Lesley A. surname: Houghton fullname: Houghton, Lesley A. organization: Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK – sequence: 6 givenname: Alexander C. surname: Ford fullname: Ford, Alexander C. organization: Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33110014$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkk1vEzEQhi1URNPCTwBZ4sJliz93Y3FqIyiVCkQKiOPK653NOnjXqe0lyr-v27QSygVfrBk_74w9r8_QyehHQOgtJRdUcKI-6s36gvy7VCVfoBmVFSsIE_QEzXKSFYpV5BSdxbghhEpWyVfolHNKcyRmaHeJv_u_4PA3SL1vcfJ44XSMtttjPbZ4NTXr4KctXupkYUwR_7apxzdXK3ylI7TYj_haxxS8HRPEZEft8Go_bJMf4mOFZdyb3ju_tiYfLYPvrIP4Gr3stIvw5mk_R7--fP65-Frc_ri-WVzeFobPmSqACcOB8EZpKUpRMk4aVYFs5l1ZKsapBNFVDVVsDgbmrWoFGFo1uuvanDD8HH041N0GfzflC9aDjQac0yP4KdZMSEkrwSTN6PsjdOOnkN-TKSmFKmklWabePVFTM0Bbb4MddNjXzyPNwKcDYIKPMUBXG5vy8PyYgraupqR-NLDOBtbHBma1PFI_N_ifThx0O-8ShPjHTTsIdQ_apf6ACy4KRhglLAfFw99Q_B5km62Y |
CitedBy_id | crossref_primary_10_1016_j_cgh_2021_04_011 crossref_primary_10_1111_nmo_14391 crossref_primary_10_14309_ajg_0000000000001247 crossref_primary_10_1111_apt_17404 crossref_primary_10_1111_nmo_14756 crossref_primary_10_1111_nmo_14877 crossref_primary_10_1371_journal_pone_0268491 crossref_primary_10_1111_apt_16351 crossref_primary_10_1038_s41575_023_00794_z crossref_primary_10_1080_17474124_2025_2455586 crossref_primary_10_1080_17474124_2023_2223975 crossref_primary_10_14309_ctg_0000000000000613 crossref_primary_10_1016_S2468_1253_23_00072_9 crossref_primary_10_1016_S2468_1253_24_00245_0 crossref_primary_10_1001_jama_2021_6758 crossref_primary_10_1038_s41598_023_45605_2 crossref_primary_10_1111_nmo_14800 crossref_primary_10_3389_fncel_2022_1010107 crossref_primary_10_1002_jgh3_12770 crossref_primary_10_1007_s43076_024_00389_w crossref_primary_10_7759_cureus_68156 crossref_primary_10_1111_apt_17111 crossref_primary_10_1016_j_gastha_2023_01_004 crossref_primary_10_1111_apt_17634 crossref_primary_10_1111_apt_16589 crossref_primary_10_1016_S2468_1253_21_00131_X crossref_primary_10_1111_apt_16184 crossref_primary_10_1186_s12859_023_05567_8 crossref_primary_10_1111_apt_17790 crossref_primary_10_1053_j_gastro_2024_05_010 crossref_primary_10_1016_j_jclinepi_2023_02_020 crossref_primary_10_1038_s41575_024_01033_9 crossref_primary_10_1016_j_cgh_2022_09_019 crossref_primary_10_1016_j_cgh_2023_04_032 crossref_primary_10_1055_a_1708_0277 crossref_primary_10_1111_nmo_14773 crossref_primary_10_1016_j_cgh_2024_05_042 crossref_primary_10_1111_nmo_14898 crossref_primary_10_1016_j_gie_2024_11_019 crossref_primary_10_1080_19490976_2024_2360233 crossref_primary_10_1016_j_cgh_2021_04_043 crossref_primary_10_1080_17474124_2023_2242775 crossref_primary_10_1111_apt_17735 crossref_primary_10_1111_nmo_14268 crossref_primary_10_1111_nmo_14940 crossref_primary_10_1111_nmo_14347 crossref_primary_10_1016_j_cgh_2023_02_016 crossref_primary_10_1111_apt_17815 crossref_primary_10_3389_fpubh_2022_947097 crossref_primary_10_1002_jgh3_12741 crossref_primary_10_1111_apt_16440 crossref_primary_10_1111_apt_16247 crossref_primary_10_1111_apt_16322 crossref_primary_10_1111_apt_16443 crossref_primary_10_5009_gnl230396 crossref_primary_10_3390_v16071054 crossref_primary_10_1186_s12876_024_03239_2 |
Cites_doi | 10.1056/NEJMoa1505180 10.1097/01.meg.0000231755.42963.c6 10.1038/s41395-018-0026-7 10.1038/ajg.2011.358 10.1046/j.1365-2036.2003.01456.x 10.1053/j.gastro.2016.02.031 10.1111/nmo.13483 10.1111/nmo.13872 10.1016/j.cgh.2019.07.007 10.1038/ajg.2012.255 10.1007/s11121-011-0201-1 10.1016/j.cgh.2012.02.029 10.1056/NEJMoa1004409 10.1136/gutjnl-2011-300474 10.1111/j.1365-2036.2004.02007.x 10.1136/gutjnl-2018-318160 10.1053/j.gastro.2004.12.006 10.1053/j.gastro.2018.08.021 10.1038/ajg.2017.41 10.1016/j.cgh.2016.12.032 10.1016/j.cgh.2019.05.037 10.1053/j.gastro.2017.11.279 10.1111/j.1365-2036.2008.03881.x 10.1111/nmo.12886 10.1002/nur.21974 10.1136/bmj.h701 10.1097/MEG.0b013e3283333b61 10.1111/j.1600-0447.1983.tb09716.x 10.1001/jama.285.17.2208 10.1111/apt.14207 10.1111/apt.13738 10.1111/j.1365-2036.2009.04074.x 10.1136/gutjnl-2020-321191 10.1186/s12916-020-1505-4 10.1111/nmo.13663 10.1111/j.1365-2036.2010.04402.x 10.1016/j.cgh.2018.02.043 10.1111/apt.14238 10.1056/NEJMra1607547 10.1111/j.2517-6161.1974.tb00994.x 10.1053/j.gastro.2016.02.014 10.1037/a0027127 10.1111/apt.15325 10.1111/j.1365-2036.2005.02671.x 10.2307/2136404 10.1016/S2468-1253(19)30243-2 10.1053/j.gastro.2018.03.063 |
ContentType | Journal Article |
Copyright | Wolters Kluwer Copyright © 2020 by The American College of Gastroenterology. 2020 by The American College of Gastroenterology |
Copyright_xml | – notice: Wolters Kluwer – notice: Copyright © 2020 by The American College of Gastroenterology. – notice: 2020 by The American College of Gastroenterology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.14309/ajg.0000000000000975 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1572-0241 |
EndPage | 381 |
ExternalDocumentID | 33110014 10_14309_ajg_0000000000000975 00000434-202102000-00029 |
Genre | Journal Article |
GeographicLocations | United Kingdom |
GeographicLocations_xml | – name: United Kingdom |
GroupedDBID | --- 0R~ 123 23M 36B 39C 4.4 53G 5RE 6J9 70F 7X7 88E 8FI 8FJ 8GM AAAAV AAGIX AAHPQ AAIQE AAJCS AAMOA AAQKA AASCR AASXQ ABASU ABDIG ABJNI ABLJU ABOCM ABPXF ABUWG ABVCZ ABXYN ABZZY ACGFO ACGFS ACILI ACKTT ACLDA ACNWC ACOAL ACXJB ACZKN ADBBV ADFRT ADGGA ADHPY AEBDS AENEX AEXYK AFBFQ AFDTB AFEBI AFEXH AFKRA AFNMH AFUWQ AGAYW AHMBA AHOMT AHQNM AHQVU AHSBF AINUH AJCLO AJIOK AJNWD AJRNO AJZMW AKCTQ AKRWK AKULP ALIPV ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BENPR BPHCQ BVXVI BYPQX C45 CCPQU CS3 DIWNM EBS EE. EEVPB EJD EMB ERAAH F5P FCALG FDB FDQFY FYUFA GNXGY GQDEL HLJTE HMCUK HZ~ IHE IKREB IKYAY IPNFZ JSO M1P O9- ODMTH OPUJH OVD OVDNE P0W P2P PHGZM PHGZT PQQKQ PROAC PSQYO RIG RLZ RNT RNTTT SJN TEORI TSPGW UKHRP XIF --K -Q- .55 .GJ 1B1 1OC 31~ 3O- 4G. 5VS AAEDT AALRI AAQFI AAQQT AAQXK AAXUO AAYXX ABAWZ ABWVN ACRPL ACXQS ADMUD ADNKB ADNMO ADSXY AEETU AFBPY AFFNX AGQPQ AHVBC AI. AJAOE CAG CITATION COF EMOBN FEDTE FGOYB HVGLF LH4 LW6 M41 N4W NQ- PJZUB PPXIY R2- ROL RPZ SEW SSZ SV3 UDS VH1 X7M XPP ZGI ZXP ZZMQN ACIJW CGR CUY CVF ECM EIF NPM SNX 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c3829-e24c3e03b9a54646230b97e5b8f6692315e4f7b1928ece8d9d4ec17baffdecec3 |
IEDL.DBID | 7X7 |
ISSN | 0002-9270 1572-0241 |
IngestDate | Tue Aug 05 08:37:19 EDT 2025 Fri Jul 25 07:38:01 EDT 2025 Wed Feb 19 02:25:01 EST 2025 Thu Apr 24 23:00:51 EDT 2025 Thu Aug 07 07:28:45 EDT 2025 Fri May 16 03:50:57 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | Copyright © 2020 by The American College of Gastroenterology. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3829-e24c3e03b9a54646230b97e5b8f6692315e4f7b1928ece8d9d4ec17baffdecec3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 33110014 |
PQID | 2554961752 |
PQPubID | 2041977 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2455174251 proquest_journals_2554961752 pubmed_primary_33110014 crossref_citationtrail_10_14309_ajg_0000000000000975 crossref_primary_10_14309_ajg_0000000000000975 wolterskluwer_health_00000434-202102000-00029 |
PublicationCentury | 2000 |
PublicationDate | 2021-February-01 2021-02-00 2021-02-01 20210201 |
PublicationDateYYYYMMDD | 2021-02-01 |
PublicationDate_xml | – month: 02 year: 2021 text: 2021-February-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | The American journal of gastroenterology |
PublicationTitleAlternate | Am J Gastroenterol |
PublicationYear | 2021 |
Publisher | Wolters Kluwer Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins |
Publisher_xml | – name: Wolters Kluwer – name: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins |
References | Rao (R5-20250804) 2012; 107 Chey (R7-20250804) 2017; 112 Black (R10-20250804) 2018; 155 Koloski (R20-20250804) 2016; 44 Clevers (R22-20250804) 2018; 16 Stone (R49-20250804) 1974; 36 Holroyd (R55-20250804) 2001; 285 Labus (R40-20250804) 2004; 20 Hookway (R24-20250804) 2015; 350 Vrieze (R48-20250804) 2012; 17 Ford (R2-20250804) 2017; 376 Drossman (R13-20250804) 2005; 128 Black (R12-20250804) 2020; 18 Han (R33-20250804) 2019; 42 Brenner (R6-20250804) 2018; 113 Hungin (R50-20250804) 2003; 17 Cohen (R41-20250804) 1983; 24 Pimentel (R9-20250804) 2011; 364 Drossman (R4-20250804) 2009; 29 Everitt (R26-20250804) 2019; 68 Boeckxstaens (R30-20250804) 2016; 28 Magidson (R45-20250804) 2002; 20 Derrick (R42-20250804) 2015; 10 Lanza (R46-20250804) 2013; 14 Zigmond (R38-20250804) 1983; 67 Koloski (R18-20250804) 2006; 18 Jones (R21-20250804) 2017; 15 Andrews (R15-20250804) 2005; 22 Lovell (R1-20250804) 2012; 10 Black (R11-20250804) 2020; 69 Zamani (R23-20250804) 2019; 50 Polster (R31-20250804) 2017; 46 Lackner (R28-20250804) 2018; 155 Polster (R32-20250804) 2019; 31 Black (R34-20250804) 2020; 18 Everitt (R27-20250804) 2019; 4 Riehl (R56-20250804) 2019; 31 Black (R35-20250804) 2020; 32 Ringström (R53-20250804) 2010; 22 Spiller (R39-20250804) 2010; 32 Koloski (R19-20250804) 2012; 61 Black (R51-20250804) 2017; 46 Black (R25-20250804) 2020; 69 Lembo (R8-20250804) 2016; 374 Burton (R52-20250804) 2020; 18 Palsson (R37-20250804) 2016; 150 Drossman (R54-20250804) 2018; 154 Lee (R17-20250804) 2009; 30 Palsson (R14-20250804) 2012; 107 Mearin (R3-20250804) 2016; 150 Khoshkrood-Mansoori (R16-20250804) 2009; 18 |
References_xml | – volume: 374 start-page: 242 year: 2016 ident: R8-20250804 article-title: Eluxadoline for irritable bowel syndrome with diarrhea publication-title: N Engl J Med doi: 10.1056/NEJMoa1505180 – volume: 18 start-page: 1101 year: 2006 ident: R18-20250804 article-title: Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: A population-based study publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/01.meg.0000231755.42963.c6 – volume: 10 start-page: 1 year: 2015 ident: R42-20250804 article-title: Tests for comparing two proportions with partially overlapping samples publication-title: J Appl Quantitative Methods – volume: 113 start-page: 735 year: 2018 ident: R6-20250804 article-title: Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: Results of two phase 3 randomized clinical trials publication-title: Am J Gastroenterol doi: 10.1038/s41395-018-0026-7 – volume: 107 start-page: 286 year: 2012 ident: R14-20250804 article-title: IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: Implications for treatment publication-title: Am J Gastroenterol doi: 10.1038/ajg.2011.358 – volume: 17 start-page: 643 year: 2003 ident: R50-20250804 article-title: The prevalence, patterns and impact of irritable bowel syndrome: An international survey of 40,000 subjects publication-title: Aliment Pharmacol Ther doi: 10.1046/j.1365-2036.2003.01456.x – volume: 150 start-page: 1393 year: 2016 ident: R3-20250804 article-title: Bowel disorders publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.02.031 – volume: 31 start-page: e13483 year: 2019 ident: R32-20250804 article-title: Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: A population-based study publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.13483 – volume: 32 start-page: e13872 year: 2020 ident: R35-20250804 article-title: Anxiety-related factors associated with symptom severity in irritable bowel syndrome publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.13872 – volume: 18 start-page: 1238 year: 2020 ident: R12-20250804 article-title: Relative efficacy of tegaserod in a systematic review and network meta-analysis of licensed therapies for irritable bowel syndrome with constipation publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2019.07.007 – volume: 107 start-page: 1714 year: 2012 ident: R5-20250804 article-title: 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation publication-title: Am J Gastroenterol doi: 10.1038/ajg.2012.255 – volume: 14 start-page: 157 year: 2013 ident: R46-20250804 article-title: Latent class analysis: An alternative perspective on subgroup analysis in prevention and treatment publication-title: Prev Sci doi: 10.1007/s11121-011-0201-1 – volume: 10 start-page: 712 year: 2012 ident: R1-20250804 article-title: Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2012.02.029 – volume: 364 start-page: 22 year: 2011 ident: R9-20250804 article-title: Rifaximin therapy for patients with irritable bowel syndrome without constipation publication-title: N Engl J Med doi: 10.1056/NEJMoa1004409 – volume: 61 start-page: 1284 year: 2012 ident: R19-20250804 article-title: The brain—Gut pathway in functional gastrointestinal disorders is bidirectional: A 12-year prospective population-based study publication-title: Gut doi: 10.1136/gutjnl-2011-300474 – volume: 20 start-page: 89 year: 2004 ident: R40-20250804 article-title: The visceral sensitivity index: Development and validation of a gastrointestinal symptom-specific anxiety scale publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2004.02007.x – volume: 69 start-page: 74 year: 2020 ident: R11-20250804 article-title: Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: Systematic review and network meta-analysis publication-title: Gut doi: 10.1136/gutjnl-2018-318160 – volume: 128 start-page: 580 year: 2005 ident: R13-20250804 article-title: A prospective assessment of bowel habit in irritable bowel syndrome in women: Defining an alternator publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.12.006 – volume: 155 start-page: 1753 year: 2018 ident: R10-20250804 article-title: Efficacy of secretagogues in patients with irritable bowel syndrome with constipation: Systematic review and network meta-analysis publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.08.021 – volume: 112 start-page: 763 year: 2017 ident: R7-20250804 article-title: Tenapanor treatment of patients with constipation-predominant irritable bowel syndrome: A phase 2, randomized, placebo-controlled efficacy and safety trial publication-title: Am J Gastroenterol doi: 10.1038/ajg.2017.41 – volume: 15 start-page: 1014 year: 2017 ident: R21-20250804 article-title: Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2016.12.032 – volume: 18 start-page: 392 year: 2020 ident: R34-20250804 article-title: Epidemiological, clinical, and psychological characteristics of individuals with self-reported irritable bowel syndrome based on the Rome IV vs Rome III criteria publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2019.05.037 – volume: 154 start-page: 1140 year: 2018 ident: R54-20250804 article-title: Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): A Rome Foundation Working Team Report publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.11.279 – volume: 29 start-page: 329 year: 2009 ident: R4-20250804 article-title: Clinical trial: Lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2008.03881.x – volume: 28 start-page: 1134 year: 2016 ident: R30-20250804 article-title: Phenotyping of subjects for large scale studies on patients with IBS publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.12886 – volume: 42 start-page: 382 year: 2019 ident: R33-20250804 article-title: Symptom-based latent classes of persons with irritable bowel syndrome publication-title: Res Nurs Health doi: 10.1002/nur.21974 – volume: 350 start-page: h701 year: 2015 ident: R24-20250804 article-title: Irritable bowel syndrome in adults in primary care: Summary of updated NICE guidance publication-title: BMJ doi: 10.1136/bmj.h701 – volume: 22 start-page: 420 year: 2010 ident: R53-20250804 article-title: Structured patient education is superior to written information in the management of patients with irritable bowel syndrome: A randomized controlled study publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/MEG.0b013e3283333b61 – volume: 67 start-page: 361 year: 1983 ident: R38-20250804 article-title: The hospital anxiety and depression scale publication-title: Acta Psychiatr Scand doi: 10.1111/j.1600-0447.1983.tb09716.x – volume: 285 start-page: 2208 year: 2001 ident: R55-20250804 article-title: Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: A randomized controlled trial publication-title: JAMA doi: 10.1001/jama.285.17.2208 – volume: 46 start-page: 529 year: 2017 ident: R31-20250804 article-title: Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.14207 – volume: 18 start-page: 413 year: 2009 ident: R16-20250804 article-title: Irritable bowel syndrome: A population based study publication-title: J Gastrointestin Liver Dis – volume: 44 start-page: 592 year: 2016 ident: R20-20250804 article-title: Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: A 1-year population-based prospective study publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13738 – volume: 30 start-page: 643 year: 2009 ident: R17-20250804 article-title: Irritable bowel syndrome is strongly associated with generalized anxiety disorder: A community study publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2009.04074.x – volume: 69 start-page: 1441 year: 2020 ident: R25-20250804 article-title: Efficacy of psychological therapies for irritable bowel syndrome: Systematic review and network meta-analysis publication-title: Gut doi: 10.1136/gutjnl-2020-321191 – volume: 18 start-page: 34 year: 2020 ident: R52-20250804 article-title: Functional somatic disorders: Discussion paper for a new common classification for research and clinical use publication-title: BMC Med doi: 10.1186/s12916-020-1505-4 – volume: 20 start-page: 37 year: 2002 ident: R45-20250804 article-title: Latent class models for clustering: A comparison with K means publication-title: Can J Mark Res – volume: 31 start-page: e13663 year: 2019 ident: R56-20250804 article-title: Nuances of the psychogastroenterology patient: A predictive model for gastrointestinal quality of life improvement publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.13663 – volume: 32 start-page: 811 year: 2010 ident: R39-20250804 article-title: The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2010.04402.x – volume: 16 start-page: 1244 year: 2018 ident: R22-20250804 article-title: Development of irritable bowel syndrome features over a 5-year period publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2018.02.043 – volume: 46 start-page: 697 year: 2017 ident: R51-20250804 article-title: Editorial: Subgroups in irritable bowel syndrome-more than just diarrhoea and constipation? publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.14238 – volume: 376 start-page: 2566 year: 2017 ident: R2-20250804 article-title: Irritable bowel syndrome publication-title: N Engl J Med doi: 10.1056/NEJMra1607547 – volume: 36 start-page: 111 year: 1974 ident: R49-20250804 article-title: Cross-validatory choice and assessment of statistical predictions publication-title: J R Stat Soc Ser B (Methodological) doi: 10.1111/j.2517-6161.1974.tb00994.x – volume: 150 start-page: 1481 year: 2016 ident: R37-20250804 article-title: Rome IV diagnostic questionnaires and tables for investigators and clinicians publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.02.014 – volume: 68 start-page: 1613 year: 2019 ident: R26-20250804 article-title: Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): A multicentre randomised trial publication-title: Gut – volume: 17 start-page: 228 year: 2012 ident: R48-20250804 article-title: Model selection and psychological theory: A discussion of the differences between the akaike information criterion (AIC) and the Bayesian information criterion (BIC) publication-title: Psychol Methods doi: 10.1037/a0027127 – volume: 50 start-page: 132 year: 2019 ident: R23-20250804 article-title: Systematic review with meta-analysis: The prevalence of anxiety and depression in patients with irritable bowel syndrome publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.15325 – volume: 22 start-page: 935 year: 2005 ident: R15-20250804 article-title: Prevalence and demographics of irritable bowel syndrome: Results from a large web-based survey publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2005.02671.x – volume: 24 start-page: 385 year: 1983 ident: R41-20250804 article-title: A global measure of perceived stress publication-title: J Health Soc Behav doi: 10.2307/2136404 – volume: 4 start-page: 863 year: 2019 ident: R27-20250804 article-title: Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(19)30243-2 – volume: 155 start-page: 47 year: 2018 ident: R28-20250804 article-title: Improvement in gastrointestinal symptoms after cognitive behavior therapy for refractory irritable bowel syndrome publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.03.063 |
SSID | ssj0015275 |
Score | 2.5630872 |
Snippet | Conventionally, patients with irritable bowel syndrome (IBS) are subgrouped based on their predominant bowel habit. Given the relevance of psychological... INTRODUCTION:Conventionally, patients with irritable bowel syndrome (IBS) are subgrouped based on their predominant bowel habit. Given the relevance of... |
SourceID | proquest pubmed crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 372 |
SubjectTerms | Abdominal Pain - physiopathology Adolescent Adult Aged Aged, 80 and over Anxiety Anxiety - psychology Constipation - physiopathology Depression - psychology Diarrhea - physiopathology Drugs Female Gastroenterology Humans Irritable bowel syndrome Irritable Bowel Syndrome - classification Irritable Bowel Syndrome - physiopathology Irritable Bowel Syndrome - psychology Latent Class Analysis Male Middle Aged Patients Stress, Psychological - psychology United Kingdom Variables Young Adult |
Title | A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00000434-202102000-00029 https://www.ncbi.nlm.nih.gov/pubmed/33110014 https://www.proquest.com/docview/2554961752 https://www.proquest.com/docview/2455174251 |
Volume | 116 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3fb5RAEJ5omxiNMf6qorVZE1-xlN0F9sncmf7Q5i6X1qb3RnaXRastnIXa9L93hoVrq4neCzlggfDBzDfszDcA79BDxtKkZZgJjQFKYl2oy9iGUhpJ0Zh1Xd3aZJrsHYnPcznvP7g1fVrlYBM7Q13Ulr6RbyL1FQrdrYw_LH6G1DWKZlf7Fhp3YZWkyyilK50vAy7q2CoH-qviNOoreASP1Kb-_tVrFw4_RamGN33TX4TzATy8rGkOu_nRpbDfcEQ7j-FRzyDZyEP-BO646incm_Rz5M_gcsSm9S93yiZdc2jW1qzrfHlSXjFdFQxNRVfKwWZeUrVhxyftN_ZpfMjG6NIKVldsVzfteU1SEmgB6GyHV2eLtj5ruiPcMpps5rt-N8_haGf7y8e9sG-vEFqexSp0sbDcRdwojbAI5EGRUamTJiuThHifdKJMDVLAzFmXFaoQzm6lRpdlgSssX4OVqq7cS2AIbJoUDsmFIwE2rRVPpDNFJlOL_0wAYrixue21x6kFxmlOMQjhkSMe-Z94BPB-OWzhxTf-N2B9QC3v38Umv35yAni73IxvEU2N6MrVF7iPkCTZjWQvgBce7eUZOSdZvS0RQHgL_txXqvqLEFygwaH4OfKl-rF69e-LeQ33aYDPAF-Hlfb8wr1BgtOaje4p3oDV0f7B8T4ux9vT2cFvKlT27w |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTuJDCPE5AgOMBI9hWWwn8QNCK2y0bK0qtom9BdtxxmBLypJR9Z_ib-QcJ2UDCZ7WtzZ1bOXOd7_L-X4H8AI9ZMhVnPsJkxigRNr4Mg-1z7niNhrTpqlbG42jwT77cMAPluBnVwtjj1V2NrEx1Fmp7TvyNYS-TKC75eGb6Xffdo2y2dWuhYZTi20zn2HIVr0evkP5vgzDrc29twO_7Srga5qEwjch09QEVAmJq2Ho_gMlYsNVkkeRhTvcsDxWiHwSo02SiYwZvR4rmecZ_qAp3vcKLDOKoUwPlvub48nHRd6ChzHvALcI46CtGWI0EGvy66FjS-w-wh5uPO8N_4K4N-DmrLRZ8-pbc2j-nOvbug23WsxKNpyS3YElU9yFq6M2K38PZhtkXP4wx2TUtKMmdUmaXptH-ZzIIiNonJriETJxJK4V-XRUfyHD_i7poxPNSFmQ97KqT0tLXoE2x862Oz-Z1uVJ1dzhgpkmE9dnvLoP-5fy6B9ArygL8xAIqlIcZQbhjLGUb1IKGnGjsoTHGr8pD1j3YFPdsp3bphvHqY16rDxSlEf6pzw8eLUYNnV0H_8bsNpJLW13f5X-1lUPni8u4761yRhZmPIM_8O4JQlHeOnBipP2YkZKLZHfOvPAvyD-1NXGukUwytDE2Yg9cOQAoXj078U8g2uDvdFOujMcbz-G63awO3--Cr369Mw8QXhVq6etThP4fNnb6BeanzL4 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwED6NIU0ghPhNYYCR4DE0TewkfkBoY5SV0arSmOhbsB0HBltSloyq_xp_HXdxUjaQ4Gl9a1PHVu5891189x3AM_SQgdBx7iVcYYASGeupPDCeEFpQNGZsU7c2nkS7B_zdTMzW4GdXC0NplZ1NbAx1Vhp6R95H6MslulsR9PM2LWK6M3w1_-5RByk6ae3aaTgV2bPLBYZv1cvRDsr6eRAM33x4veu1HQY8EyaB9GzATWj9UEuFK-MIBXwtYyt0kkcRQR9heR5rREGJNTbJZMatGcRa5XmGP5gQ73sJLsehGNAei2erYI-6xYoOessg9tvqIR76sq--fna8id1HUprjWb_4F9i9CtcWJZ2fV9-a9PkzTnB4A6636JVtOXW7CWu2uAUb4_Z8_jYsttik_GGP2LhpTM3qkjVdNw_zJVNFxtBMNWUkbOroXCv28bD-wkbb-2wb3WnGyoK9VVV9UhKNBVofmm1_eTyvy-OqucM5g82mruN4dQcOLuTB34X1oizsfWCoVHGUWQQ2lsjflJJhJKzOEhEb_KZ7wLsHm5qW95zabxylFP-QPFKUR_qnPHrwYjVs7og__jdgs5Na2tqBKv2ttT14urqMO5iOZVRhy1P8DxdEF45Aswf3nLRXM4YhUfoNeA-8c-JPXZWsWwQPORo7it19RxMQyAf_XswT2MDNk74fTfYewhUa6xLRN2G9Pjm1jxBn1fpxo9AMPl30DvoFvxg1yA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Novel+Method+to+Classify+and+Subgroup+Patients+With+IBS+Based+on+Gastrointestinal+Symptoms+and+Psychological+Profiles&rft.jtitle=The+American+journal+of+gastroenterology&rft.au=Black%2C+Christopher+J.&rft.au=Yiannakou%2C+Yan&rft.au=Guthrie%2C+Elspeth+A.&rft.au=West%2C+Robert&rft.date=2021-02-01&rft.issn=0002-9270&rft.eissn=1572-0241&rft.volume=116&rft.issue=2&rft.spage=372&rft.epage=381&rft_id=info:doi/10.14309%2Fajg.0000000000000975&rft.externalDBID=n%2Fa&rft.externalDocID=10_14309_ajg_0000000000000975 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9270&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9270&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9270&client=summon |